4
Changes in Ownership
Edesa Biotech, Inc. Filed Acc 0001144204-19-013781
Options or other derivatives
- Director acquired 357 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| SAMPAT MAYANK D. Director | 2019-03-12 | Grant or award · Share Option (Right to Buy) | +357 | 357 | D: show line 1 in the form |
Loading xslF345X03/tv516190_4.xml…